🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT02918994
Active, not recruiting Not applicable

LearningRx Cognitive Training for Brain Injury

NCT02918994 · tracked via the Priya Life Science USA tracker
Sponsor
Gibson Institute of Cognitive Research
Phase
Not applicable
Started
2016-09
Last updated
2026-02-13

Condition(s) studied

Traumatic Brain Injury (TBI)Acquired Brain InjuryPost COVID-19 Cognitive Impairment

Investigational drug(s) / intervention(s)

LearningRx cognitive training

LearningRx cognitive training: A clinician will deliver three 90-minute cognitive training sessions per week for 14 weeks. There are 16 different categories of leveled training procedures sequenced in intensity and difficulty for a total of 530 training tasks. Participants will receive training in-person or remotely depending on state of residence.

Study summary

The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, daily functioning, and workplace self-efficacy for participants with Traumatic Brain Injury (TBI) /Acquired Brain Injury (ABI).

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: \- Age 18+ previously diagnosed with TBI/ABI Exclusion Criteria: * No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging for participants receiving MRI only

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Gibson Institute of Cognitive Research Colorado Springs Colorado
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02918994 on ClinicalTrials.gov ↗ ← All trials in the USA